NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
Aroa Biosurgery Limited (AU: ARX)
ARX Technical Analysis
5
As on 1st Apr 2025 ARX STOCK Price closed @ 0.42 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.61 & Strong Sell for SHORT-TERM with Stoploss of 0.75 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ARXSTOCK Price
Open | 0.44 | Change | Price | % |
High | 0.44 | 1 Day | 0.00 | 0.00 |
Low | 0.42 | 1 Week | -0.04 | -8.70 |
Close | 0.42 | 1 Month | -0.17 | -28.81 |
Volume | 174932 | 1 Year | -0.34 | -44.74 |
52 Week High 0.87 | 52 Week Low 0.44 |
AU Australia Most Active Stocks
WHK | 0.03 | 200.00% |
BTR | 0.02 | 0.00% |
CRS | 0.06 | -33.33% |
JAY | 0.00 | % |
ATH | 0.01 | 0.00% |
PLS | 1.59 | -5.36% |
TLS | 4.27 | 1.43% |
PNR | 0.16 | -5.88% |
CLA | 0.01 | % |
OZM | 0.09 | 50.00% |
AU Australia Top Gainers Stocks
AU Australia Top Losers Stocks
ARX Daily Charts |
ARX Intraday Charts |
Whats New @ Bazaartrend |
ARX Free Analysis |
|
ARX Important Levels Intraday
RESISTANCE | 0.46 |
RESISTANCE | 0.45 |
RESISTANCE | 0.44 |
RESISTANCE | 0.43 |
SUPPORT | 0.41 |
SUPPORT | 0.40 |
SUPPORT | 0.39 |
SUPPORT | 0.38 |
ARX Forecast April 2025
4th UP Forecast | 0.82 |
3rd UP Forecast | 0.69 |
2nd UP Forecast | 0.61 |
1st UP Forecast | 0.53 |
1st DOWN Forecast | 0.31 |
2nd DOWN Forecast | 0.23 |
3rd DOWN Forecast | 0.15 |
4th DOWN Forecast | 0.02 |
ARX Weekly Forecast
4th UP Forecast | 0.57 |
3rd UP Forecast | 0.52 |
2nd UP Forecast | 0.49 |
1st UP Forecast | 0.46 |
1st DOWN Forecast | 0.38 |
2nd DOWN Forecast | 0.35 |
3rd DOWN Forecast | 0.32 |
4th DOWN Forecast | 0.27 |
ARX Forecast2025
4th UP Forecast | 1.31 |
3rd UP Forecast | 1.02 |
2nd UP Forecast | 0.85 |
1st UP Forecast | 0.67 |
1st DOWN Forecast | 0.17 |
2nd DOWN Forecast | -0.01 |
3rd DOWN Forecast | -0.18 |
4th DOWN Forecast | -0.47 |
Aroa Biosurgery Limited ( AU Australia Symbol : ARX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ARX Other Details
Segment | EQ | |
Market Capital | 389723840.00 | |
Sector | Healthcare | |
Industry | Medical Devices | |
Offical website | > echo $website ; ?> |
ARX Address
![]() |
ARX Latest News
ARX Business Profile
Aroa Biosurgery Limited, a regenerative medicine company, engages in the developing, manufacturing, and selling of medical devices for wound and tissue repair using extracellular matrix (ECM) technology in the United States and internationally. Its products include Endoform Natural and Endoform Antimicrobia for treating acute and chronic wounds; Myriad Matrix, an engineered ECM for soft tissue repair, reinforcement, and complex wounds; Myriad Morcells, a morcellized (powdered) format of Myriad Matrix for soft tissue repair and complex wounds; and Reinforced Bioscaffolds, a surgical product for use in ventral hernia repair and abdominal wall reconstruction. The company was incorporated in 2007 and is headquartered in Auckland, New Zealand. Address: 64 Richard Pearse Drive, Auckland, New Zealand, 2022
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service